A protein-based booster vaccine made by Novavax, which works differently to the Pfizer and Moderna jabs, is also available. Moderna hopes to launch a combined flu and Covid vaccine later in 2025 ...

Pfizer and BioNTech have formally asked for FDA approval of a third dose of their COVID-19 vaccine BNT162b2 in people aged over 16, as the US prepares to get its booster campaign underway.

A woman receives a booster dose of Pfizer-BioNTech vaccine against the coronavirus disease (COVID-19) at the Police hospital in Bangkok 31,170 people played the daily Crossword recently.

The spring booster campaign starts in England on 1 April, but vaccines are also available privately. Pfizer scientist Dr Nicholas Kitchin shares the moment he heard the the Covid jab was a success.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

(Reuters) -Johnson & Johnson is planning to ask U.S. federal regulators this week to authorize a booster shot of its COVID-19 ...

The NHS spring booster campaign is offering Covid jab to groups of vulnerable patients across the UK. Around 7.5 million ...

Broader protection induced by combination of COVID adenovirus vaccine plus CiVax TM compared to 2-shot mRNA vaccination series ...

(Reuters) -U.S. health regulators authorized the use of Omicron-tailored COVID-19 booster shots from Moderna (NASDAQ:MRNA) Inc ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...